JP2018502575A5 - - Google Patents

Download PDF

Info

Publication number
JP2018502575A5
JP2018502575A5 JP2017535832A JP2017535832A JP2018502575A5 JP 2018502575 A5 JP2018502575 A5 JP 2018502575A5 JP 2017535832 A JP2017535832 A JP 2017535832A JP 2017535832 A JP2017535832 A JP 2017535832A JP 2018502575 A5 JP2018502575 A5 JP 2018502575A5
Authority
JP
Japan
Prior art keywords
cells
tgfβ
superfamily
cell
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017535832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018502575A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/051270 external-priority patent/WO2016108240A1/en
Publication of JP2018502575A publication Critical patent/JP2018502575A/ja
Publication of JP2018502575A5 publication Critical patent/JP2018502575A5/ja
Priority to JP2021020986A priority Critical patent/JP7723482B2/ja
Priority to JP2025084549A priority patent/JP2025118972A/ja
Pending legal-status Critical Current

Links

JP2017535832A 2014-12-30 2015-12-30 網膜色素上皮細胞集団の評価法 Pending JP2018502575A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021020986A JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法
JP2025084549A JP2025118972A (ja) 2014-12-30 2025-05-21 網膜色素上皮細胞集団の評価法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462097753P 2014-12-30 2014-12-30
US62/097,753 2014-12-30
US201562116980P 2015-02-17 2015-02-17
US62/116,980 2015-02-17
US201562195304P 2015-07-22 2015-07-22
US62/195,304 2015-07-22
PCT/IL2015/051270 WO2016108240A1 (en) 2014-12-30 2015-12-30 Assessing retinal pigment epithelial cell populations

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2020085170A Division JP2020146044A (ja) 2014-12-30 2020-05-14 網膜色素上皮細胞集団の評価法
JP2021020986A Division JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法

Publications (2)

Publication Number Publication Date
JP2018502575A JP2018502575A (ja) 2018-02-01
JP2018502575A5 true JP2018502575A5 (cg-RX-API-DMAC7.html) 2019-02-14

Family

ID=55305031

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2017535832A Pending JP2018502575A (ja) 2014-12-30 2015-12-30 網膜色素上皮細胞集団の評価法
JP2020085170A Pending JP2020146044A (ja) 2014-12-30 2020-05-14 網膜色素上皮細胞集団の評価法
JP2021020986A Active JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法
JP2023038688A Pending JP2023078266A (ja) 2014-12-30 2023-03-13 網膜色素上皮細胞集団の評価法
JP2025084549A Pending JP2025118972A (ja) 2014-12-30 2025-05-21 網膜色素上皮細胞集団の評価法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2020085170A Pending JP2020146044A (ja) 2014-12-30 2020-05-14 網膜色素上皮細胞集団の評価法
JP2021020986A Active JP7723482B2 (ja) 2014-12-30 2021-02-12 網膜色素上皮細胞集団の評価法
JP2023038688A Pending JP2023078266A (ja) 2014-12-30 2023-03-13 網膜色素上皮細胞集団の評価法
JP2025084549A Pending JP2025118972A (ja) 2014-12-30 2025-05-21 網膜色素上皮細胞集団の評価法

Country Status (8)

Country Link
US (2) US20180011092A1 (cg-RX-API-DMAC7.html)
EP (2) EP3916085A1 (cg-RX-API-DMAC7.html)
JP (5) JP2018502575A (cg-RX-API-DMAC7.html)
AU (3) AU2015373051B2 (cg-RX-API-DMAC7.html)
CA (1) CA2972580A1 (cg-RX-API-DMAC7.html)
ES (1) ES2880346T3 (cg-RX-API-DMAC7.html)
IL (2) IL314417A (cg-RX-API-DMAC7.html)
WO (1) WO2016108240A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015373050B2 (en) 2014-12-30 2022-09-29 Cell Cure Neurosciences Ltd. RPE cell populations and methods of generating same
CA2972700A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Methods of treating retinal diseases
EP3328995B1 (en) * 2015-07-29 2021-03-31 Hadasit Medical Research Services And Development Large scale production of retinal pigment epithelial cells
EP3331995A1 (en) * 2015-08-05 2018-06-13 Cell Cure Neurosciences Ltd. Preparation of photoreceptors for the treatment of retinal diseases
CN108138144A (zh) * 2015-08-05 2018-06-08 细胞治疗神经科学有限公司 视网膜色素上皮细胞的制备
WO2018232745A1 (zh) * 2017-06-23 2018-12-27 珠海亿胜生物制药有限公司 生产可溶性重组人碱性成纤维细胞生长因子(rh-bFGF)的方法
BR112020013238A2 (pt) 2017-12-29 2020-12-01 Cell Cure Neurosciences Ltd. composição e método para formular células do epitélio pigmentar da retina bem como uso da dita composição para tratar uma condição retiniana
CA3225834A1 (en) * 2021-07-28 2023-02-02 Lineage Cell Therapeutics, Inc. Expansion of retinal pigment epithelium cells
WO2026028838A1 (ja) * 2024-07-31 2026-02-05 コニカミノルタ株式会社 細胞の分析方法及び目的物質の生産方法

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
SG49267A1 (en) 1989-08-14 1998-05-18 Photogenesis Inc Surgical instrument and cell isolation and transplantation
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US6045791A (en) 1992-03-06 2000-04-04 Photogenesis, Inc. Retinal pigment epithelium transplantation
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5755785A (en) 1994-08-12 1998-05-26 The University Of South Florida Sutureless corneal transplantation method
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5941250A (en) 1996-11-21 1999-08-24 University Of Louisville Research Foundation Inc. Retinal tissue implantation method
GB9715584D0 (en) 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
GB0001930D0 (en) 2000-01-27 2000-03-22 Novartis Ag Organic compounds
WO2002060875A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
AU2003201745A1 (en) 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
US8354277B2 (en) 2004-10-12 2013-01-15 Technion Research & Development Foundation Ltd. Isolated primate embryonic cells derived from extended blastocysts
WO2006070370A2 (en) 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
US20080003676A1 (en) * 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
EP2128244A4 (en) 2007-01-18 2012-05-09 Riken PROCESS FOR INDUCTION / DIFFERENTIATION TO A PHOTOREZEPTORZELLE
CA2684460C (en) * 2007-04-18 2017-01-03 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
US20090226955A1 (en) * 2007-12-21 2009-09-10 University Of Miami Immortalized retinal pigmented epithelial cells
IL281453B (en) 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
US20120258451A1 (en) 2011-04-08 2012-10-11 Advanced Cell Technology, Inc. Laser isolation of viable cells
IL287381B2 (en) 2011-11-14 2024-04-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human rpe cells and uses thereof
AU2013216382B2 (en) 2012-01-31 2018-08-02 Hadasit Medical Research Services And Development Ltd. Methods of selecting retinal pigmented epithelial cells
US9850463B2 (en) * 2012-02-01 2017-12-26 The Regents Of The University Of California Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation
CN102618497B (zh) * 2012-03-15 2013-10-02 中国人民解放军第三军医大学第一附属医院 利用人骨髓间充质干细胞制备视网膜色素上皮细胞的方法
WO2013184809A1 (en) 2012-06-05 2013-12-12 The Regents Of The University Of California Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells
DK2951290T3 (en) 2013-02-01 2018-01-22 Us Health PROCEDURE FOR PREPARING RETINAL PIGMENTAL EPIT (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)
AU2014363032A1 (en) * 2013-12-11 2016-06-09 Pfizer Limited Method for producing retinal pigment epithelial cells
WO2015175504A1 (en) * 2014-05-12 2015-11-19 The Johns Hopkins University Differentiation of human pluripotent stem cells into retinal pigment epithelium using hif1 inhibitors
AU2015373050B2 (en) 2014-12-30 2022-09-29 Cell Cure Neurosciences Ltd. RPE cell populations and methods of generating same
CA2972700A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Methods of treating retinal diseases

Similar Documents

Publication Publication Date Title
Roozafzoon et al. Dental pulp stem cells differentiation into retinal ganglion-like cells in a three dimensional network
Venugopal et al. Bioengineered corneal epithelial cell sheet from mesenchymal stem cells—A functional alternative to limbal stem cells for ocular surface reconstruction
US8703411B2 (en) Cryopreservation of umbilical cord tissue for cord tissue-derived stem cells
JP2018502576A5 (cg-RX-API-DMAC7.html)
JP2010524457A5 (cg-RX-API-DMAC7.html)
Culmes et al. Endothelial differentiation of adipose-derived mesenchymal stem cells is improved by epigenetic modifying drug BIX-01294
JP2025118972A5 (cg-RX-API-DMAC7.html)
Jurga et al. Neurogenic potential of human umbilical cord blood: Neural‐like stem cells depend on previous long‐term culture conditions
Xiong et al. Optimal time for passaging neurospheres based on primary neural stem cell cultures
CN105683359A (zh) 将从间充质干细胞诱导的多能干细胞分化为肝细胞的方法
Suri et al. Human platelet lysate as a replacement for fetal bovine serum in limbal stem cell therapy
Li et al. Enriching new transplantable RGC-like cells from retinal organoids for RGC replacement therapy
KR20170049775A (ko) 망막색소상피 분화 유도용 조성물
Hohwieler et al. “Miniguts” from plucked human hair meet Crohn’s disease
Mueller et al. Osteoblastic differentiation of Wharton jelly biopsy specimens and their mesenchymal stromal cells after serum-free culture
Alexander et al. Stromal cells cultivated from the choroid of human eyes display a mesenchymal stromal cell (MSC) phenotype and inhibit the proliferation of choroidal vascular endothelial cells in vitro
Kotasová et al. Expandable lung epithelium differentiated from human embryonic stem cells
KR101779763B1 (ko) 증식력 및 분화능이 개선된 간엽줄기세포를 포함하는 폐질환 예방 또는 치료용 약학적 조성물
CN104450606B (zh) 汗腺细胞诱导培养基及其应用
Wong et al. Modeling hereditary diffuse leukoencephalopathy with axonal spheroids using microglia-sufficient brain organoids
Su et al. Stem cells from human exfoliated deciduous teeth differentiate toward neural cells in a medium dynamically cultured with Schwann cells in a series of polydimethylsiloxanes scaffolds
KR20230026952A (ko) 전분화능 줄기세포 유래 상피 오가노이드의 제조방법
JP6446222B2 (ja) 軟骨分化培養液、及び軟骨組織の製造方法
Edel et al. An optimized method to produce Human-Induced pluripotent stem Cell-Derived limbal stem cells easily adaptable for clinical use
CN106794278A (zh) 产生具有皮肤附属器官的全厚皮肤的方法